Literature DB >> 15148120

Long-term results of lower-lid suspension blepharoplasty: a 30-year experience.

Carlo P Honrado1, Norman J Pastorek.   

Abstract

BACKGROUND: Muscle suspension blepharoplasty remains a reliable method to tighten the loose skin and muscle of the lower eyelid.
OBJECTIVE: To evaluate the 30-year experience of the senior author (N.J.P.) with the skin-muscle suspension technique for lower-lid blepharoplasty. PATIENTS AND METHODS: Of 4395 patients who underwent lower-lid blepharoplasty, 3988 had muscle suspension blepahroplasty performed with adequate follow-up.
RESULTS: Results of the 30-year review showed that most patients were very satisfied with the procedure. There were 67 complications (2 hematomas, 1 poor scar, 24 cases of scleral show <1 mm, and 40 cases of chemosis). Chemosis resolved in 2 to 8 weeks, and there were no cases of ectropion, scleral show greater than 1 mm, dry eye, or vision loss. Revision surgery was needed in 41 patients, all of whom were satisfied after the secondary procedure.
CONCLUSION: Despite the recent drift toward orbital fat preservation for lower-lid blepharoplasty, conventional lower-lid muscle suspension offers the surgeon a reliable method to tighten the loose skin and muscle of the lower eyelid and give the patient a more attractive, youthful appearance.

Entities:  

Mesh:

Year:  2004        PMID: 15148120     DOI: 10.1001/archfaci.6.3.150

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  3 in total

1.  Blepharoplasty: an overview.

Authors:  Milind N Naik; Santosh G Honavar; Sima Das; Savari Desai; Niteen Dhepe
Journal:  J Cutan Aesthet Surg       Date:  2009-01

2.  Changes in Tear Meniscus Height Following Lower Blepharoplasty as Measured by Optical Coherence Tomography.

Authors:  Sang Min Lee; Sok Joong Chung; Jong Seo Park; Helen Lew
Journal:  Korean J Ophthalmol       Date:  2018-10

Review 3.  Updates on upper eyelid blepharoplasty.

Authors:  Kasturi Bhattacharjee; Diva Kant Misra; Nilutparna Deori
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.